{
  "symbol": "GLPG",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap market capitalization", "clinical trial developments"],
    "riskScore": 7,
    "reason": "Galapagos N.V. operates in the biotechnology sector, which is prone to speculation, and has a small-cap market capitalization, making it susceptible to retail-driven price movements."
  }
}